Irvine, CA, USA – July 1, 2025 – EnChannel Medical Ltd., a global leader in cardiac electrophysiology innovation, today announced it has signed a definitive agreement to acquire the AcQMap™ High Resolution Imaging and Mapping platform assets from Acutus Medical Inc. The acquisition includes...
EnChannel Medical Raises $82.2M in Oversubscribed Series-B Financing to Advance Full-Chamber 5D Atrial Fibrillation Mapping and Personalized Pulsed-Field Ablation Therapy GUANGZHOU, China – May 1, 2025 - EnChannel Medical, a breakthrough innovator in cardiac electrophysiology, today announced the...
EnChannel Medical is excited to share our first-in-human clinical results at HRS 2025. Please stop by and engage with our Physician partners!
EnChannel will be presenting at HRS 2025, San Diego Convention Center April 24-27, 2025. If you’d like additional information, contact our marketing team.
EnChannel presented our pre-clinical work utilizing our novel FocaLinear and Balloon pulsed field ablation catheters. Pulsed Field Ablation Balloon Catheter for Pulmonary Vein Isolation and Circular Atrial Lesions: A Preclinical Evaluation of Safety and Feasibility – May 18, from 1:30 – 3:30 PM...
EnChannel Medical Announces Closing of Series A Financing to Develop Next Generation Cardiac Arrhythmia Mapping System and Pulsed Field Ablation Technology Oversubscribed financing round raised $27 million to support development and registration of novel mapping and ablation systems to treat...